152 related articles for article (PubMed ID: 24901552)
21. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
Higgins MJ; Graham SJ
Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
[No Abstract] [Full Text] [Related]
22. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
[TBL] [Abstract][Full Text] [Related]
23. Open innovation and intellectual property: time for a reboot?
Judd DB
Drug Discov Today; 2013 Oct; 18(19-20):907-9. PubMed ID: 23958455
[No Abstract] [Full Text] [Related]
24. Which patent and where? Why international patent transparency by companies is needed for medicines.
Beall RF; Attaran A
Nat Biotechnol; 2016 Sep; 34(9):923-6. PubMed ID: 27606455
[No Abstract] [Full Text] [Related]
25. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
26. Research on the pharmaceutical intellectual property protection and supervision of pharmacy administration.
Xu Z; Chen W
Pak J Pharm Sci; 2017 May; 30(3(Special)):1081-1087. PubMed ID: 28671085
[TBL] [Abstract][Full Text] [Related]
27. Patent quality.
Sklan A
Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
[TBL] [Abstract][Full Text] [Related]
28. The 'real world' utility of miRNA patents: lessons learned from expressed sequence tags.
McLeod BW; Hayman ML; Purcell AL; Marcus JS; Veitenheimer E
Nat Biotechnol; 2011 Feb; 29(2):129-33. PubMed ID: 21301436
[TBL] [Abstract][Full Text] [Related]
29. Intellectual property and its role in the pharmaceutical industry.
Atkinson JD; Jones R
Future Med Chem; 2009 Dec; 1(9):1547-50. PubMed ID: 21425976
[No Abstract] [Full Text] [Related]
30. Patent watch: Drug patenting in India: looking back and looking forward.
Sampat BN; Shadlen KC
Nat Rev Drug Discov; 2015 Aug; 14(8):519-20. PubMed ID: 26184492
[No Abstract] [Full Text] [Related]
31. [Specificities of patent protection in the pharmaceutical industry: modalities and traits of intellectual property].
Jannuzzi AH; Vasconcellos AG; de Souza CG
Cad Saude Publica; 2008 Jun; 24(6):1205-18. PubMed ID: 18545747
[TBL] [Abstract][Full Text] [Related]
32. US courts struggle with new patent infringement standards.
Jones P
Nat Biotechnol; 2004 Apr; 22(4):461-3. PubMed ID: 15085803
[No Abstract] [Full Text] [Related]
33. Enforcing pharmaceutical and biotech patent rights in China.
Zhang YP; Deng MM
Nat Biotechnol; 2008 Nov; 26(11):1235-40. PubMed ID: 18997760
[No Abstract] [Full Text] [Related]
34. Intellectual property protection: strategies for antibody inventions.
Storz U
MAbs; 2011; 3(3):310-7. PubMed ID: 21494091
[TBL] [Abstract][Full Text] [Related]
35. Intellectual property. Fixing the legal framework for pharmaceutical research.
Knowles SM
Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
[No Abstract] [Full Text] [Related]
36. Legal developments and practical implications of gene patenting on targeted drug discovery and development.
Klein RD
Clin Pharmacol Ther; 2010 Jun; 87(6):633-5. PubMed ID: 20485317
[TBL] [Abstract][Full Text] [Related]
37. Is Canada patent deal obstructing Ebola vaccine development?
Attaran A; Nickerson JW
Lancet; 2014 Nov; 384(9958):e61. PubMed ID: 25467593
[No Abstract] [Full Text] [Related]
38. International intellectual property strategies for therapeutic antibodies.
Storz U
MAbs; 2011; 3(6):596-606. PubMed ID: 22123063
[TBL] [Abstract][Full Text] [Related]
39. IP issues facing researchers by Gino D'Oca.
Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R
Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778
[TBL] [Abstract][Full Text] [Related]
40. Intellectual property. U.S. Court opens door to free trade in ideas.
Malakoff D
Science; 2003 Sep; 301(5640):1643. PubMed ID: 14500946
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
